US Tech 100

19,168.00

0.52%

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
AMEX
Dor Biopharma (DOR)
Dor Biopharma (DOR) News

DOR

Dor (DOR)

Dor Biopharma

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:DOR

1

Date	Time	Source	Headline	Symbol	Company
04/07/2006	9:19AM	Business Wire	DOR BioPharma Announces Advances in Mucosal Vaccines for Botulinum Toxin; Antigens are Made Using Dowpharma's Pfenex Expression	AMEX:DOR	Dor Biopharma
04/06/2006	3:28PM	Business Wire	DOR BioPharma Announces Private Equity Financing of $3.65 Million with Institutional Investors	AMEX:DOR	Dor Biopharma
03/30/2006	9:00AM	Business Wire	DOR BioPharma Reports Year End 2005 Financial Results and Accomplishments; DOR Provides Guidance on Regulatory Filings on orBec	AMEX:DOR	Dor Biopharma
02/08/2006	9:25AM	Business Wire	DOR BioPharma Provides Financial Guidance and Update on European Regulatory Plans for orBec(R)	AMEX:DOR	Dor Biopharma
01/30/2006	5:48PM	Business Wire	DOR BioPharma Announces Positive Phase I Results of RiVax(TM), its Vaccine Against Ricin Toxin; Vaccine is Immunogenic and Well	AMEX:DOR	Dor Biopharma
01/25/2006	10:31AM	Business Wire	DOR BioPharma Achieves Manufacturing Milestone in Development of RiVax(TM); DOR and Its Collaborators Achieve 2nd Milestone Ahea	AMEX:DOR	Dor Biopharma
01/20/2006	8:10AM	Business Wire	DOR BioPharma Reports Positive New Survival Findings from Previously Completed Phase II and III Clinical Trials of orBec(R); Res	AMEX:DOR	Dor Biopharma
01/19/2006	9:26AM	Business Wire	DOR BioPharma Secures $6 Million Equity Commitment from Fusion Capital	AMEX:DOR	Dor Biopharma
11/15/2005	9:04AM	Business Wire	DOR BioPharma Plans FDA NDA and European MAA Filing Strategy for orBec	AMEX:DOR	Dor Biopharma
11/14/2005	4:26PM	Business Wire	DOR BioPharma Inc. Reports Third Quarter 2005 Financial Results and Reviews Recent Achievements; Conference Call Scheduled for N	AMEX:DOR	Dor Biopharma
11/07/2005	7:00AM	Business Wire	DOR BioPharma to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference	AMEX:DOR	Dor Biopharma
11/02/2005	6:00AM	Business Wire	DOR BioPharma Executes Letter of Intent for Acquisition of Gastrotech Pharma; Acquisition Bolsters Biotherapeutics Pipeline	AMEX:DOR	Dor Biopharma
11/01/2005	4:34PM	Business Wire	DOR BioPharma Receives Notice of Delisting from American Stock Exchange; Company to Continue to Negotiate Potential Compliance-A	AMEX:DOR	Dor Biopharma
10/14/2005	9:17AM	Business Wire	DOR BioPharma Provides Update on Programs and Corporate Matters	AMEX:DOR	Dor Biopharma
09/15/2005	5:41PM	PR Newswire (US)	Dr. Chris Dale, Vice President, Technology, Cambrex Biopharmaceuticals and Dr. Robert N. Brey, Chief Scientific Officer, DOR Bio	AMEX:DOR	Dor Biopharma
07/26/2005	1:07PM	PR Newswire (US)	DOR BioPharma and Dowpharma Enter Into a Joint Development Agreement for BT-VACC(TM), DOR's Oral Vaccine Against Botulinum Toxin	AMEX:DOR	Dor Biopharma
06/15/2005	6:30AM	Business Wire	DOR BioPharma, Inc. Announces Positive Interim Results from Phase I Clinical Trial of RiVax, Its Ricin Toxin Vaccine	AMEX:DOR	Dor Biopharma
06/13/2005	11:14AM	Business Wire	DOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Security and Connectivity Conference	AMEX:DOR	Dor Biopharma
05/04/2005	10:51AM	Business Wire	DOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference	AMEX:DOR	Dor Biopharma
05/04/2005	10:51AM	Business Wire	DOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference	AMEX:DOR	Dor Biopharma
05/04/2005	8:30AM	Business Wire	DOR BioPharma Appoints T. Jerome Madison to Board of Directors	AMEX:DOR	Dor Biopharma
05/04/2005	8:30AM	Business Wire	DOR BioPharma Appoints T. Jerome Madison to Board of Directors	AMEX:DOR	Dor Biopharma
01/07/2005	8:30AM	PR Newswire (US)	DOR BioPharma and Cambrex Enter into a Development and Manufacturing Process Agreement for RiVax(TM)	AMEX:DOR	Dor Biopharma